During the past decade, Maine Medical Center- Scarborough Campus conducted 77 clinical trials. In the 10-year time frame, 77 clinical trials started and 38 clinical trials were completed, i.e. on average, 49.4% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 29 clinical trials were completed. i.e. 82.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Maine Medical Center- Scarborough Campus" #1 sponsor was "National Cancer Institute (NCI)" with 36 trials, followed by "NRG Oncology" with 16 trials sponsored, "Gynecologic Oncology Group" with 7 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Maine Medical Center- Scarborough Campus" #1 collaborator was "National Cancer Institute (NCI)" with 50 trials as a collaborator, "NRG Oncology" with 26 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Radiation Therapy Oncology Group" with 4 trials as a collaborator and "NCIC Clinical Trials Group" with 3 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "Maine Medical Center- Scarborough Campus" are "Recurrent Ovarian Carcinoma" (8 trials), "Recurrent Fallopian Tube Carcinoma" (7 trials), "Recurrent Primary Peritoneal Carcinoma" (7 trials), "Endometrial Serous Adenocarcinoma" (5 trials) and "Ovarian Seromucinous Carcinoma" (5 trials). Many other conditions were trialed in "Maine Medical Center- Scarborough Campus" in a lesser frequency.

Most popular intervention types in "Maine Medical Center- Scarborough Campus" are "Drug" (81 trials), "Other" (60 trials), "Radiation" (45 trials), "Procedure" (31 trials) and "Biological" (30 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (34 trials), "Questionnaire Administration" (24 trials), "Laboratory Biomarker Analysis" (21 trials), "Paclitaxel" (20 trials) and "Carboplatin" (17 trials). Other intervention names were less common.

The vast majority of trials in "Maine Medical Center- Scarborough Campus" are 61 trials for "All" genders, 40 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Maine Medical Center- Scarborough Campus". undefined are not yet recruiting, 34 are recruiting, 44 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 22 completed trials in Maine Medical Center- Scarborough Campus, 2 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Maine Medical Center- Scarborough Campus, 2 "Phase 1" clinical trials were conducted, 43 "Phase 2" clinical trials and 64 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 11 trials that are defined as “Not Applicable".

Maine Medical Center- Scarborough Campus has several departments that took part in Clinical trials: "Maine Hemophilia and Thrombosis Center" - 7 trials, "Maine Medical Center - Division of Pulmonary and Critical Care Medicine" - 2 trials